SlipstreamJobs tracks this role from the company's public career site. Apply directly on the employer's site.
Hippocratic AI is seeking a Director of Corporate Development to lead the company's M&A and partnership strategy in healthcare services. This is a strategic dealmaking role focused on sourcing, evaluating, and executing acquisitions that expand the platform across patient access, triage, scheduling, and after-hours services.
You will own the full deal lifecycle: building segmented market maps and target lists, developing investment theses with clear synergy logic, leading cross-functional diligence (commercial, financial, legal, HR, tech/security, clinical ops), and driving integration to realize value. You'll build and maintain a proactive pipeline, develop financial models and investment materials (LBO cases, purchase price bridges, synergy cases, NPV/IRR analyses), partner with external advisors and financing sources, and track value-creation levers including revenue expansion, SG&A optimization, and vendor consolidation.
Success means closing acquisitions that deliver on synergy cases and financial projections, establishing robust diligence and risk-management processes, maintaining active deal flow with sourced opportunities reflecting market intelligence, and building institutional playbooks and integration frameworks that scale across the organization.
You bring 5+ years in PE, investment banking, or corporate development with multiple closed transactions. You have strong financial modeling and underwriting skills, comfort with debt financing and definitive documents, and deep healthcare services knowledge including working understanding of HIPAA/BAA. Healthcare contact center or outsourced clinical operations exposure is valuable. You're an excellent executive communicator, skilled at influencing across finance, legal, operations, and external advisors. Strategic thinking on M&A, integration, and synergy realization is essential.
The role involves periodic travel (30–40%) for sourcing, diligence, and integration. Relocation assistance is available. Hippocratic AI recently raised $126M Series C at $3.5B valuation, backed by leading healthcare and AI investors including CapitalG, General Catalyst, a16z, and Kleiner Perkins. The company is building a healthcare-only, safety-focused LLM platform co-founded by CEO Munjal Shah and a team of physicians, hospital leaders, and AI pioneers from Stanford, Johns Hopkins, Google, Meta, Microsoft, and NVIDIA.
